Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma

References

• Stiff PJ, Unger JM, Cook JR, et al. Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. N Engl J Med 2013;369:1681–1690.
   PubMed Web of Science ®Google Scholar
• Dreyling M, Thieblemont C, Gallamini A, et al. ESMO consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 2013;24:857–877.
   PubMed Web of Science ®Google Scholar
• Ghielmini M, Vitolo U, Kimby E, et al. ESMO guidelines consensus conference on malignant lymphoma 2011. Part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol 2013;24:561–576.
   PubMed Web of Science ®Google Scholar
• Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813–1826.
   PubMed Web of Science ®Google Scholar
• Tan SS, Uyl-de Groot C, Huijgens PC, et al. Stem cell transplantation in Europe: trends and prospects. Eur J Cancer 2007;43:2359–2365.
   PubMed Web of Science ®Google Scholar
• Passweg JR, Baldomero H, Bregni M, et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013;48:1161–1167.
   PubMed Web of Science ®Google Scholar
• Agence de biomédecine. Activité nationale de greffe de CSH [Internet]. 2012. p. 1–48. Available from: http://www.agence-biomedecine.fr/annexes/bilan2012/donnees/cellules/04-national/pdf/nationale.pdf
   Google Scholar
• Afessa B, Tefferi A, Dunn WF, et al. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003;31:1715–1721.
   PubMed Web of Science ®Google Scholar
• Soubani AO, Kseibi E, Bander JJ, et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004;126:1604–1611.
   PubMed Web of Science ®Google Scholar
• Gordon C, Oakervee HE, Kaya B, et al. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia 2005;60:340–347.
   PubMed Web of Science ®Google Scholar
• Kew AK, Couban S, Patrick W, et al. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant 2006;12:301–305.
   PubMed Web of Science ®Google Scholar
• Hampshire P, Welch C, McCrossan L, et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009;13(4):R137.
   PubMed Web of Science ®Google Scholar
• Bird GT, Farquhar-Smith P, Wigmore T, et al. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 2012;108:452–459.
   PubMed Web of Science ®Google Scholar
• Bach PB, Schrag D, Nierman DM, et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001;98:3234–3240.
   PubMed Web of Science ®Google Scholar
• Naeem N, Reed MD, Creger RJ, et al. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplant 2006;37:119–1133.
   PubMed Web of Science ®Google Scholar
• Gilli K, Remberger M, Hjelmqvist H, et al. Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant 2010;45:682–688.
   PubMed Web of Science ®Google Scholar
• Bayraktar UD, Shpall EJ, Liu P, et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 2013;31:4207–4214.
   PubMed Web of Science ®Google Scholar
• Pène F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006;24:643–649.
   PubMed Web of Science ®Google Scholar
• Townsend WM, Holroyd A, Pearce R, et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 2013;161:578–586.
   PubMed Web of Science ®Google Scholar
• Zucca E, Thieblemont C, Martinelli G, et al. Treatment for patients with indolent and mantle cell lymphoma. Lancet 2013;382(9898):1094.
   PubMed Web of Science ®Google Scholar
• Thiéry G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005;23:4406–4413.
   PubMed Web of Science ®Google Scholar
• Lengliné E, Raffoux E, Lemiale V, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012;53:1352–1359.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006;32:808–822.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–710.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Hughes WT, Armstrong D, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551–73.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz K, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52.
   Web of Science ®Google Scholar
• Paz HL, Crilley P, Weinar M, et al. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 1993;104:527–531.
   PubMed Web of Science ®Google Scholar
• Jackson SR, Tweeddale MG, Barnett MJ, et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998;21:697–704.
   PubMed Web of Science ®Google Scholar
• Khassawneh BY, White P, Anaissie EJ, et al. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002;121:185–188.
   PubMed Web of Science ®Google Scholar
• Trinkaus MA, Lapinsky SE, Crump M, et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant 2009;43:411–415.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium – a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 2013;31:2810–2818.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010;182:1038–1046.
   PubMed Web of Science ®Google Scholar
• Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001;33:41–47.
   PubMed Web of Science ®Google Scholar
• Collin B, Leather HL, Wingard JR, et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001;33:947–953.
   PubMed Web of Science ®Google Scholar
• Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013;98:1826–1835.
   PubMed Web of Science ®Google Scholar
• Auner HW, Sill H, Mulabecirovic A, et al. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 2002;81:374–377.
   PubMed Web of Science ®Google Scholar
• Santos KB, Neto AEH, Silva GA, et al. Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution. Sao Paulo Med J 2012;130:10–16.
   PubMed Web of Science ®Google Scholar
• Gil L, Styczynski J, Komarnicki M. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 2007;35:421–427.
   PubMed Web of Science ®Google Scholar
• Reich G, Mapara MY, Reichardt P, et al. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 2001;27:525–529.
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M. The role of primary antifungal prophylaxis in patients with haematological malignancies. Clin Microbiol Infect 2014;20(Suppl. 6):19–26.
   PubMed Web of Science ®Google Scholar
• Nesher L, Rolston KVI. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis 2013;56:711–717.
   PubMed Web of Science ®Google Scholar